title: Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis.
abstract: Peripheral blood counts and factors influencing haematological recovery in 98 patients with a relapse-free survival of > or =1 year treated with high-dose chemotherapy (HDC) and peripheral stem-cell transplantation (PSCT) for haematological malignancies were analysed. One year after PSCT full haematological recovery was demonstrated for haemoglobin (Hb) in 47% of patients, for the white blood cell count (WBC) in 94%, and for platelets in 64%; 39% had a trilineage recovery. In the multivariate analysis, recovery was influenced by age (P=0.002), number of reinfused CD34+ cells (P=0.016), Hb at start of HDC (P=0.001), and platelets at start of HDC (P=0.008). One year following PSCT, 61% of patients still have subnormal values in one or more haematopoietic cell lineage, suggesting a limited bone-marrow reserve. Long-term recovery is highly dependent on age, blood counts at start of HDC and number of reinfused CD34+ cells without a threshold, all reflecting the residual function of bone marrow before HDC. Reinfusing more CD34+ cells can accelerate long-term haematological recovery.
authors.affiliation: Department of Medical Oncology, University Hospital Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands.
authors.forename: P
authors.initials: P
authors.lastname: Nieboer
authors.forename: E G E
authors.initials: EG
authors.lastname: de Vries
authors.forename: E
authors.initials: E
authors.lastname: Vellenga
authors.forename: W T A
authors.initials: WT
authors.lastname: van der Graaf
authors.forename: N H
authors.initials: NH
authors.lastname: Mulder
authors.forename: W J
authors.initials: WJ
authors.lastname: Sluiter
authors.forename: J Th M
authors.initials: JT
authors.lastname: de Wolf
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001792:Blood Platelets; D004911:Erythrocyte Volume; D005260:Female; D006085:Graft Survival; D006098:Granulocytes; D019337:Hematologic Neoplasms / Q000628:therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007958:Leukocyte Count; D007962:Leukocytes; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D010976:Platelet Count; D016896:Treatment Outcome
chemical_list: D006454:Hemoglobins